The urocortins: Mechanisms of cardioprotection and therapeutic potential

被引:13
作者
Lawrence, K. M. [1 ]
Latchman, D. S. [1 ]
机构
[1] UCL, Inst Child Hlth, Mol Biol Unit, London WC1E 6BT, England
关键词
corticotrophin-releasing hormone; urocortin; cardiac ischaemia and reperfusion injury; affymetrix gene chip microarrays; affective disorders; cardiomyocyte mitochondria;
D O I
10.2174/138955706778560111
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The study of the Urocortin family of peptides is becoming increasingly important clinically, as new discoveries have revealed that their roles in the body are extremely diverse. They range from being involved in the aetiology of affective disorders, boosting the immune system, to cardioprotection during ischaemia and reperfusion injury. Therefore, it is important to understand how these peptides become activated, how they activate different cell types and finally their intracellular signalling pathways. Such studies may enable scientists to develop clinical therapies based on their mechanism of action, which may be used to alleviate a diverse range of pathologies.
引用
收藏
页码:1119 / 1126
页数:8
相关论文
共 99 条
[31]  
JIN ZQ, 2000, AM J PHYSIOL-HEART C, V282, pH1970
[32]   Signal transduction characteristics of the corticotropin-releasing hormone receptors in the feto-placental unit [J].
Karteris, E ;
Grammatopoulos, D ;
Randeva, H ;
Hillhouse, EW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1989-1996
[33]   Distribution of urocortin-like immunoreactivity in the central nervous system of the frog Rana esculenta [J].
Kozicz, T ;
Arimura, A ;
Maderdrut, JL ;
Lázár, G .
JOURNAL OF COMPARATIVE NEUROLOGY, 2002, 453 (02) :185-198
[34]  
Kozicz T, 1998, J COMP NEUROL, V391, P1, DOI 10.1002/(SICI)1096-9861(19980202)391:1<1::AID-CNE1>3.0.CO
[35]  
2-6
[36]   Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent [J].
Latchman, DS .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1999, 80 (04) :189-196
[37]   Urocortin [J].
Latchman, DS .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2002, 34 (08) :907-910
[38]   Urocortin protects against ischemic injury via a MAPK-dependent pathway [J].
Latchman, DS .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) :167-169
[39]   Cardioprotection mediated by urocortin is dependent upon PKCFε activation [J].
Lawrence, KM ;
Kabir, AMN ;
Bellahcene, M ;
Davidson, S ;
Mesquita, RS ;
Cao, XB ;
McCormick, J ;
Carroll, CJ ;
Chanalaris, A ;
Townsend, PA ;
Hubank, M ;
Stephanou, A ;
Knight, RA ;
Marber, MS ;
Latchman, DS .
FASEB JOURNAL, 2005, 19 (03) :831-+
[40]   The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage [J].
Lawrence, KM ;
Townsend, P ;
Davidson, SM ;
Carroll, CJ ;
Eaton, S ;
Hubank, M ;
Knight, RA ;
Stephanou, A ;
Latchman, DS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (02) :479-486